fda warning letters bpc-157 peptide FDA's Overreach on Compounded Peptides fda warning letter bpc-157 unapproved

In research environments, BPC-157 is referenced in preclinical and exploratory studies examining biochemical and molecular mechanisms under controlled laboratory conditions

Long-term Neuroprotection: Helps protect against neurodegenerative conditions by maintaining neuron health and function, thereby prolonging cognitive longevity

However, some of the peptide is absorbed systemically from the gut

For children, Walsh modified his formula taking into account B12 absorption amounts found in children by Hjelt and Krasilnikoff (Hjelt, 1986)

Key Features High-purity lyophilized peptide Batch-specific Certificate of Analysis included Manufactured under strict quality standards Suitable for controlled laboratory research Packaged for professional handling environments Technical Specifications Compound: BPC-157 Format: Lyophilized powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory research In-vitro studies Biochemical analysis Preclinical model research Not intended for: Human or animal use Injection, ingestion, inhalation, or topical application Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada or any regulatory authority for clinical use

To stay on the safe side, it should be stored in clean, sealed glass or BPA-free bottles and used within a day